Related Experiment Video

Updated: Aug 31, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F

Tekle Pauzaite1, James Tollitt1, Betul Sopaci1

  • 1Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK.

Biomedicines
|August 26, 2022
PubMed

Insights

Two DDK inhibitors, PHA-767491 and XL-413, were tested for DNA replication inhibition. PHA-767491 potently inhibits DNA replication initiation and proliferation, unlike XL-413.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Precise regulation of DNA replication initiation involves cyclin-dependent kinases (CDKs) and Dbf4-dependent kinases (DDKs).
  • Chemical probes are crucial for studying DDK-mediated regulation of MCM2-7 activation and DNA replication initiation.

Purpose of the Study:

  • To assess and compare the inhibitory activities of two DDK inhibitor chemotypes, PHA-767491 and XL-413.
  • To elucidate the distinct mechanisms by which these inhibitors affect cellular proliferation, DNA replication initiation, and replisome activity.

Main Methods:

  • Cell-free and cell-based proliferation assays were employed.
  • Assays included DDK-specific phosphorylation of MCM2, S-phase entry analysis, DNA combing, and DNA replication assays.
  • E2F-mediated transcription of G1/S regulators and CDK9 inhibition were also investigated.

Main Results:

  • Both PHA-767491 and XL-413 reduced DDK-specific MCM2 phosphorylation but exhibited differential potency in preventing S-phase entry.
  • PHA-767491 demonstrated potent inhibition of DNA replication initiation, whereas XL-413 showed weak activity.
  • PHA-767491 decreased E2F-mediated transcription of cyclin A2, cyclin E1, and cyclin E2, independent of CDK9 inhibition.

Conclusions:

  • PHA-767491 is a potent inhibitor of DNA replication initiation and exhibits enhanced anti-proliferative effects.
  • PHA-767491's efficacy is attributed to its dual inhibition of DDK and the CDK2-Rb-E2F transcriptional network.
  • These findings provide a molecular basis for PHA-767491's increased anti-proliferative effects in RB+ cancer cell lines.
Keywords:
DNA replicationDbf4-dependent kinase (DDK)RB+ cancerchemical probeskinase inhibition

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.4K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K